期刊文献+

直肠腺癌术后化疗患者下肢深静脉血栓形成的抗凝治疗分析1例 被引量:1

Analysis of anticoagulant therapy for lower extremity deep venous thrombosis in one postoperative patient with rectal adenocarcinoma after chemotherapy
原文传递
导出
摘要 静脉血栓栓塞症(VTE)是肿瘤患者的重要并发症和重要死亡原因之一,也是发生率较高的一种癌症相关性血栓(CAT)[1]。抗凝治疗是目前肿瘤VTE患者的基本药物治疗策略,可有效抑制血栓蔓延、利于血栓自溶和管腔再通,从而减轻症状、降低VTE的复发率和病死率[2]。
作者 李黎 谢娟 边原 LI Li;XIE Juan;BIAN Yuan(Department of Pharmacy,Guizhou Provincial People’s Hospital,Guiyang GUIZHOU 550002,China;Departmentof Pharmacy,Personalized Drug Therapy Key Laboratory of Sichuan Province,Sichuan Academy of Medical Sciences&Sichuan Provincial People’s Hospital/Affiliated Hospital of University of Electronic Science and Technology of China,Chengdu SICHUAN 610072,China)
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2021年第1期71-74,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 国家临床药学重点专科建设项目(30305030698)。
关键词 直肠肿瘤 腺癌 静脉血栓形成 抗凝药 rectal neoplasms adenocarcinoma venous thrombosis anticoagulants
  • 相关文献

参考文献5

二级参考文献53

  • 1孙葵葵,王辰,古力夏提,罗琴.深静脉血栓形成的危险因素及临床分析[J].中华结核和呼吸杂志,2004,27(11):727-730. 被引量:82
  • 2Blann AD,Steel C,McCollum CN.The influence of smoking and of oral and transdermal nicotine on blood pressure,and haematology and coagulation indices.Thromb Haemost,1997,78(3):1093-1096.
  • 3Noboli L,Schiavi G,Bozano E,et al.Morning increase of whole blood viscosity on patient with obstructive apnea syndrome.Clin Hemorheol Microcirc,2000,22 (1):21-23.
  • 4Twelves C, Wong A, Nowacki MP, et al. Capecitabine as adjuvant treatment for stage III colon cancer [J]. N Engl 1 Med, 2005, 352 (26) : 2696-2704.
  • 5Nehls 0, Oettle H, Hartmann JT, et al. Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multi centre phase II trial [J] . Brl Cancer, 2008, 98(2): 309-315.
  • 6Cunningham D, Starling N, Rao S, et al. Capecitabine and oxaliplatin for advanced esophagogastric cancer [J]. N Engl 1 Med, 2008, 358 ( 1 ) : 3646.
  • 7Kang YK, Kang WK, Shin DB, et al. Capecitabine/ cisplatin versus 5-fluorouracill cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial [J]. Ann Oncol, 2009, 20(4): 666-673.
  • 8Okines A, Chau I, Cunningham D. Capecitabine in gastric cancer [J]. Drugs Today (Barc) , 2008, 44 (8) : 629-640.
  • 9lin M, Lu H, Li 1, et al. Ramdomized 3 -armed phase III study of S-I monotherapy versus S-l/CDDP (SP) versus 5-FU/CDDP ( FP) in patients (pts) with advanced gastric cancer (AGC) : SC- 101 study[J]. J Clin Oncol , 2008, 26(15S): 4533.
  • 10Levitan N, Dowlati A, Remick S C, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data[J]. Medicine (Baltimore), 1999,78(5): 285-291.

共引文献930

同被引文献10

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部